David M Weitman, MD, PHD | |
360 Broadway, Bangor, ME 04401-3979 | |
(207) 907-1617 | |
(207) 907-1627 |
Full Name | David M Weitman |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 360 Broadway, Bangor, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891783254 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 015055 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
David M Weitman, MD, PHD 360 Broadway, Bangor, ME 04401-3900 Ph: (207) 907-1617 | David M Weitman, MD, PHD 360 Broadway, Bangor, ME 04401-3979 Ph: (207) 907-1617 |
News Archive
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
Officials in Rwanda within the coming months plan to unveil a campaign promoting contraception and family planning to control the country's population growth and stabilize its economy, the New York Times reports.
Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.
› Verified 8 days ago
Dr. Dennis Lee Shubert, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 404 State St, Suite 101, Bangor, ME 04401 Phone: 207-433-7071 | |
James W Turner, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 417 State St Ste 221, Bangor, ME 04401 Phone: 207-973-9949 Fax: 207-973-9555 | |
Dr. Wayne Robert Waterman, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 417 State St, Suite 221, Bangor, ME 04401 Phone: 207-973-9949 Fax: 207-973-9555 | |
Dr. Mahmoud Hamdy Ibrahim Kamel, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 489 State Street, Eastern Maine Medical Center / Dept. Of Neurosurgery, Bangor, ME 04401 Phone: 207-973-9561 Fax: 207-973-9555 | |
Dr. Michael Paci, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 417 State St Ste 221, Bangor, ME 04401 Phone: 207-973-9561 | |
Dr. Joanna R Swartzbaugh, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-1617 Fax: 207-907-1627 | |
Michael Cohen, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 417 State St Ste 221, Bangor, ME 04401 Phone: 207-973-9949 |